ECS Exclusive: How we pulled off the biggest cross-border pot deal in Aussie history
On Tuesday, northern Victorian quiet achiever – the medicinal cannabis cultivator and manufacturer ECS Botanics (ASX:ECS) – revealed it secured a stunning five-year, $24 million deal to supply Perth-based MediCann Health with its top (medicinal cannabis dried flower) strain. The deal builds on the existing two-year contract and expects to deliver over four tonnes of dried cannabis flower…
ECS Botanics (ASX:ECS) secures $9.9m cannabis supply agreement
ECS Botanics (ECS) has secured a $9.9 million supply agreement for medicinal cannabis products in Germany. The company entered a binding agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis. Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product…
ECS Botanics talks green cannabis cultivation ahead of Peak Asset Management conference
ECS Botanics Holdings Ltd (ASX:ECS) managing director Nan-Maree Schoerie brings Proactive’s Elisha Newell up to speed on the company’s value proposition ahead of the Peak Asset Management Microcap Conference on Thursday, July 13
ECS Botanics (ASX:ECS) secures $11.9m to supply medicinal cannabis dried flower in Australia
ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…
ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility
Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…
ECS Botanics (ASX:ECS) hands over Tasmanian assets to Blue Buffalo
ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…
Medicinal cannabis grower ECS Botanics locks in $24m supply deal with MediCann Health
Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.
ECS Botanics talks sustainable business model and positive quarterly cashflow
ECS Botanics Ltd (ASX:ECS) managing director Nan-Maree Schoerie tells Proactive the company is an Australian medicinal cannabis cultivator and manufacturer with operations in northwest Victoria.
ECS Botanics (ASX:ECS) reports 94pc increase in Dec quarterly revenue
ECS Botanics (ECS) has reported significant growth in its December quarter, achieving its key milestone of positive quarterly cashflow.
ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis
ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
‘Our first cannabis crops failed, but we learned along the way’
Having a regulatory compliance expert for a husband may have kick-started her cannabis career, but Nan-Maree Schoerie is ploughing her own path in the industry. In the first of a two-part interview with Cannabiz, she tells of the early days of Murray Meds and explains why greenhouse growing is no longer sustainable in Australia. Sometimes in…
Germany: Likely future government supports cannabis legalisation
The country’s next coalition government plans to keep cannabis tightly regulated, party representatives said. Recreational use of cannabis is only legal in two other EU countries. Germany’s future coalition of the Social Democrats (SPD), Green party, and Free Democrats (FDP), have signalled that they are seriously considering legalizing the possession of cannabis. Representatives from the parties told…
Alex Keach “I GREW UP WITH POPPY FIELDS ALL AROUND ME. SO, WHY NOT CANNABIS?”
Australian cannabis companies are standing out as making a cautious yet steady entry into the cannabis industry. One of these companies is ECS Botanics. “ECS Botanics started as a hemp company,” says Alex Keach, founder, and Managing Director of ECS Botanics. “We have a farm in Tasmania where we grow our cannabis outdoors.” The idea…
ECS Botanics Managing Director Message: Why Australia for Medicinal Cannabis
Dear shareholders, FY21 has been a defining year for the company as we start to leverage assets that we have established in proceeding years. These include our production base, industry leading team and culture, intellectual property and systems. As a result, the company is at a major inflection point. We are now in a position…
Releaf Clinic Dispensaries to open in Noosa
Noosa is set to become the home of one of four new medicinal cannabis clinics and three dispensaries providing support for patients from the Brisbane region through to the Sunshine Coast. Releaf Clinics are set to open in Caloundra, Noosa, Mooloolaba and Fortitude Valley over the next four months with Caloundra slated to open first…
Lean, mean and green: ECS Botanics, holds medicinal cannabis licenses and GMP standards to execute on a global market opportunity
Managing Director, Alex Keach breaks down the demand dynamics for medicinal cannabis & GMP complaint products, as ECS Botanics Holdings looks to execute on a global market opportunity. After a multi-year period of development, the pieces are now in place for Australia to become a global leader in the production, sale and export of medicinal cannabis, ECS Botanics’ Managing…
Is medical marijuana legal in Australia – A Budding Industry
Australia has the potential to become the international gold standard for production of medicinal marijuana and multiple ASX-listed companies are seeking to benefit. – Is medical marijuana legal in Australia: Manufacturing of medicinal cannabis products has been legal in Australia since 2016-Australian revenue from medicinal cannabis projected to double in 2021 to $200m-Australia has the potential…
Long wait for over-the-counter cannabis Australia
Hype around the de-scheduling of low dose medicinal cannabis from a Schedule 4 to an over-the-counter Schedule 3 drug but added that steps needed to be taken before such a drug hits the market
US Researchers Begin First Clinical Trials Using Cannabis Products as Migraine Treatment
Researchers in the US have started what is the country’s first double-blind, randomized, placebo-controlled study examining the effect of cannabis products on severe migraine symptoms.
